![Shinichi Muramatsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shinichi Muramatsu
Director/Board Member at NIPPON PIGMENT COMPANY LIMITED
Shinichi Muramatsu active positions
Companies | Position | Start | End |
---|---|---|---|
NIPPON PIGMENT COMPANY LIMITED | Director/Board Member | 2018-06-27 | - |
Independent Dir/Board Member | 2018-06-27 | - |
Career history of Shinichi Muramatsu
Former positions of Shinichi Muramatsu
Companies | Position | Start | End |
---|---|---|---|
Gene Therapy Research Institution Co., Ltd.
![]() Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | Director/Board Member | - | - |
ICHIKAWA CO., LTD. | Director/Board Member | 2007-06-30 | - |
Public Communications Contact | 2010-07-15 | 2011-07-26 | |
Corporate Officer/Principal | 2010-01-18 | - | |
Sales & Marketing | 2011-07-26 | 2015-07-02 |
Statistics
International
Japan | 4 |
Operational
Director/Board Member | 3 |
Public Communications Contact | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Producer Manufacturing | 2 |
Health Technology | 2 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ICHIKAWA CO., LTD. | Producer Manufacturing |
NIPPON PIGMENT COMPANY LIMITED | Process Industries |
Private companies | 1 |
---|---|
Gene Therapy Research Institution Co., Ltd.
![]() Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | Health Technology |
- Stock Market
- Insiders
- Shinichi Muramatsu
- Experience